[{"data":1,"prerenderedAt":185},["ShallowReactive",2],{"drug-ceftriaxone":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":22,"regimens":38,"contraindications":136,"warnings":146,"renal":147,"monitoring":148,"interactions":149,"review":150,"examples":153},"ceftriaxone",1,{"fa":7,"en":8},"سفتریاکسون","Ceftriaxone","antibiotics",{"fa":11,"en":12},"سفالوسپورین نسل سوم","Third-generation cephalosporin",[14],{"name":15,"market":16},"Rocephin","US",[18,19,7,20,21],"rocephin","روسفین","سفتریاکسان","سفتریاکسون آمپول",[23],{"id":24,"form":25,"route":26,"label":27,"concentration":28,"markets":31,"refs":32},"im-250","powder-for-injection","im","IM: reconstituted to 250 mg\u002FmL (per label table)",{"amount":29,"unit":30,"perVolumeMl":5},250,"mg",[16],[33,36],{"source":34,"section":35},"fda-ceftriaxone","Dosage and Administration, Intramuscular Administration",{"source":34,"section":37},"How Supplied",[39,67,78,96,111],{"id":40,"disease":41,"label":42,"population":45,"type":49,"unit":30,"dose":50,"refs":53,"limits":56,"notes":60},"adult","susceptible-bacterial-infection",{"fa":43,"en":44},"بزرگسال: ۱ تا ۲ g یک بار در روز","Adults: 1–2 g once daily",{"minAge":46},{"value":47,"unit":48},18,"year","fixed",{"perDose":51,"perDoseMax":52,"dosesPerDay":5},1000,2000,[54],{"source":34,"section":55},"Dosage and Administration, Adults",{"maxPerDay":57,"refs":58},4000,[59],{"source":34,"section":55},[61],{"text":62,"refs":65},{"fa":63,"en":64},"یا در دو نوبت مساوی. حداقل ۲ روز پس از رفع علائم ادامه؛ معمولاً ۴ تا ۱۴ روز؛ استرپتوکوک پیوژنز حداقل ۱۰ روز.","Or in two equal doses. Continue ≥2 days after symptoms resolve; usually 4–14 days; S. pyogenes at least 10 days.",[66],{"source":34,"section":55},{"id":68,"disease":68,"label":69,"population":72,"type":49,"unit":30,"dose":74,"refs":75,"durationDays":77},"gonorrhea",{"fa":70,"en":71},"سوزاک بدون عارضه: ۲۵۰ mg عضلانی تک‌دوز","Uncomplicated gonorrhoea: 250 mg IM single dose",{"minAge":73},{"value":47,"unit":48},{"perDose":29,"dosesPerDay":5},[76],{"source":34,"section":55},{"min":5,"max":5},{"id":79,"disease":80,"label":81,"population":84,"type":86,"unit":30,"dose":87,"refs":89,"limits":92,"durationDays":95},"aom","acute-otitis-media",{"fa":82,"en":83},"اوتیت میانی حاد — کودکان: ۵۰ mg\u002Fkg عضلانی تک‌دوز (حداکثر ۱ g)","Acute otitis media — children: 50 mg\u002Fkg IM single dose (max 1 g)",{"maxAge":85},{"value":47,"unit":48},"weightBased",{"perKgPerDay":88,"dividedDoses":5},50,[90],{"source":34,"section":91},"Dosage and Administration, Pediatric Patients",{"maxPerDose":51,"refs":93},[94],{"source":34,"section":91},{"min":5,"max":5},{"id":97,"disease":98,"label":99,"population":102,"type":86,"unit":30,"dose":104,"refs":106,"limits":108},"sssi","skin-soft-tissue-infection",{"fa":100,"en":101},"عفونت پوست — کودکان: ۵۰ تا ۷۵ mg\u002Fkg\u002Fday یک بار (حداکثر ۲ g\u002Fday)","Skin infection — children: 50–75 mg\u002Fkg\u002Fday once (max 2 g\u002Fday)",{"maxAge":103},{"value":47,"unit":48},{"perKgPerDay":88,"perKgPerDayMax":105,"dividedDoses":5},75,[107],{"source":34,"section":91},{"maxPerDay":52,"refs":109},[110],{"source":34,"section":91},{"id":112,"disease":113,"label":114,"population":117,"type":86,"unit":30,"dose":119,"refs":121,"limits":123,"durationDays":126,"notes":129},"meningitis","bacterial-meningitis",{"fa":115,"en":116},"مننژیت — کودکان: ۱۰۰ mg\u002Fkg\u002Fday (حداکثر ۴ g\u002Fday)","Meningitis — children: 100 mg\u002Fkg\u002Fday (max 4 g\u002Fday)",{"maxAge":118},{"value":47,"unit":48},{"perKgPerDay":120,"dividedDoses":5},100,[122],{"source":34,"section":91},{"maxPerDay":57,"refs":124},[125],{"source":34,"section":91},{"min":127,"max":128},7,14,[130],{"text":131,"refs":134},{"fa":132,"en":133},"دوز اول ۱۰۰ mg\u002Fkg (حداکثر ۴ g)؛ سپس یک بار در روز یا دو نوبت هر ۱۲ ساعت. معمولاً وریدی و در بیمارستان.","First dose 100 mg\u002Fkg (max 4 g); then once daily or in two doses every 12 h. Usually IV in hospital.",[135],{"source":34,"section":91},[137],{"id":138,"severity":139,"text":140,"refs":143},"ci","block",{"fa":141,"en":142},"حساسیت به سفتریاکسون یا هر سفالوسپورین؛ نوزاد نارس تا سن پس از قاعدگی ۴۱ هفته؛ نوزاد ≤۲۸ روز که محلول کلسیم‌دار وریدی لازم دارد؛ تزریق وریدی محلول حاوی لیدوکائین.","Hypersensitivity to ceftriaxone or any cephalosporin; premature neonates up to 41 weeks postmenstrual age; neonates ≤28 days needing calcium-containing IV solutions; IV use of solutions containing lidocaine.",[144],{"source":34,"section":145},"Contraindications",[],[],[],[],{"status":151,"reviewer":152,"date":152},"unverified",null,[154,160,165,171,176,182],{"regimen":40,"formulation":24,"input":155,"expect":158},{"ageYears":156,"weightKg":157},40,70,{"perDose":51,"mlPerDose":159,"upperPerDose":52},4,{"regimen":68,"formulation":24,"input":161,"expect":164},{"ageYears":162,"weightKg":163},25,60,{"mlPerDose":5},{"regimen":79,"formulation":24,"input":166,"expect":169},{"ageYears":167,"weightKg":168},2,10,{"perDose":170,"mlPerDose":167},500,{"regimen":79,"formulation":24,"input":172,"expect":175},{"ageYears":173,"weightKg":174},8,30,{"perDose":51},{"regimen":97,"formulation":24,"input":177,"expect":180},{"ageYears":178,"weightKg":179},5,20,{"perDose":51,"upperPerDose":181},1500,{"regimen":112,"formulation":24,"input":183,"expect":184},{"ageYears":128,"weightKg":88},{"perDose":57},1792078532838]